Tag: ESMINT 2024
Flow diverters “particularly effective” but also associated with “non-negligible” complication rate...
An analysis presented at this year’s European Society of Minimally Invasive Neurological Therapy (ESMINT) congress (4–6 September, Marseille, France) has indicated that flow diverters...
Latest TOBAS analysis finds low neurological event rate among conservatively managed...
Patients with unruptured brain arteriovenous malformations (AVMs) who are allocated to conservative management, or ‘observation’, experience a low rate of neurological events, according to...
Anne-Christine Januel named new ESMINT president
Interventional neuroradiologist Anne-Christine Januel (Toulouse University Hospital, Toulouse, France) has been elected as the new president of the European Society of Minimally Invasive Neurological Therapy...
Evasc announces treatment milestone alongside Eclips data presentation at ESMINT 2024
Evasc Neurovascular recently announced a “landmark achievement” during the 2024 European Society of Minimally Invasive Neurological Therapy (ESMINT) congress (4–6 September, Marseille, France), reporting...
Rapid completes interim safety analysis of DISTALS study evaluating Tigertriever 13...
Rapid Medical has announced completion of the interim safety analysis from the multicentre, pivotal DISTALS study, reporting no safety concerns in medium vessel occlusions...
